Table 3.
Ref. | Sample size | Median follow-up, yr | Predictor | Primary outcome | Absolute risk of outcome (%) | RR [95%CI] |
RCT | ||||||
Laiyemo et al[11] | 1905 | 4 | ≥ 3 adenomas | ACN | 10 (7-14) vs 6 (5-7) | 1.5 [1.0-2.2] |
Bonithon-Kopp et al[9] | 552 | 3 | ≥ 3 adenomas | ACN | 18.1 vs 5.0 | 2.7 [1.2-6.4] |
Meta-analysis | ||||||
Saini I et al[10] | 5 studies | 3 | ≥ 3 adenomas | ACN | 5% risk difference (1-10) | 2.5 [1.1-6.0] |
Prospective | ||||||
1Lieberman et al[12] | 1193 | 5.5 | 1-2 | ACN | 4.6 | 1.9 [0.8-4.4] |
≥ 3 | 11.9 | 5.0 [2.1-12.0] | ||||
Chung et al[8] | 3808 | 4.5 | ≥ 3 adenomas | ACN | Not available | 3.1 [1.5-6.6] |
Registry | ||||||
Van Heijningen et al[13] | 2990 | 2 | 1 | AA | 4 | Ref |
2 | 7 | 1.6 [1.1-2.4] | ||||
3 | 8 | 2.1 [1.3-3.4] | ||||
4 | 12 | 2.0 [0.9-4.6] | ||||
≥ 5 | 18 | 3.3 [1.7-6.6] | ||||
Ng et al[18] | 4989 | 2 | AA | Not available | Adjusted OR | |
1 | 3.6 [2.6-5.0] | |||||
2 | 7.1 [4.9-10.4] | |||||
3 | 13.7 [0.9-4] |
Relative risk compared to those with no neoplasia. ACN: Advanced colonic neoplasia (includes advanced adenomas and colorectal cancer); AA: Advanced adenomas; OR: Odds ratio; RCT: Randomized control trial.